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Objectives To describe how individual schools manage 
medicines and strategies for implementation of guidance, 
to determine the nature of problems perceived by children, 
parents, teachers and healthcare professionals (HCPs) 
in relation to medicines management in schools and to 
highlight differences between these perceptions.
Design A cross-sectional survey study in which 
questionnaires were completed by children, their parents 
and carers, groups of HCPs and head teachers.
results There were 158 respondents to this survey. The 
management of medicines varies between schools and this 
reflects how policy guidance is interpreted and is revealed 
by the differences in experience described. Head teachers 
acknowledge that there is a lack of expertise about 
medicines among their staff and they rely on interpretation 
of and adherence to policy and procedure and compliance 
with training was used as a measure of good medicines 
management. There are inconsistencies in how information 
about medicines is communicated between the healthcare 
team, families and schools, and there is evidence that 
this communication is not always timely or effective. This 
results in problems with medicines at school. Parents 
emphasised the need for staff at school to understand their 
child’s condition and their medicines.
conclusions There are differences between how 
individual schools manage medicines and interpret policy 
guidance and discrepancies between the views of each 
stakeholder group. There is some evidence that medicines 
management does not always meet the needs of children 
and their families. Fewer than half of parents and HCPs are 
satisfied with how medicines are dealt with in schools.
IntrODuctIOn
Children with chronic illness and short-term 
conditions often require medication that 
may need to be administered during school 
hours. The Department for Education (DfE) 
provides guidance on medicine management 
in schools.1 The document includes state-
ments on staff training, medicines storage, 
quality and safe disposal and on record 
keeping. Individual schools are responsible 
for interpreting and implementing this guid-
ance which means that different schools opt 
to manage medicines in different ways. To 
date, we do not know whether children, their 
parents, school staff and healthcare profes-
sionals (HCPs) are satisfied with how medi-
cines are managed in schools.
Previous studies in the UK have found that 
schools have policies in place, have a desig-
nated member of staff responsible for the 
medical needs of pupils, and provide staff 
training.2 However, there is also consider-
able variation in local policy and practice.3 
There are problems with access to medi-
cines, privacy, adherence and side effects.4 5 
A recent study in Finland identified a lack of 
consistency around medicines management 
at school.6
Several studies in the USA have identi-
fied medication errors: missed doses, over-
dose, double dose, incorrect medicine, 
What this study hopes to add?
 ► Fewer than half of parents and healthcare 
professionals are satisfied with how medicines are 
dealt with in schools.
 ► Communication about medicines between 
the healthcare team, families and schools is 
inconsistent and there is evidence that it is not 
always timely or effective.
 ► Parents want school staff to better understand their 
child’s condition and their medicines.
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Original article
What is already known on this topic?
 ► In the UK, individual schools are responsible 
for interpreting and implementing guidance on 
medicines management which is provided by the 
Department for Education.
 ► Most schools have medicines management policies 
in place. However, there is considerable variation in 
policy and practice.
 ► When at school, some children have problems 
accessing medicines and with privacy and 
adherence. They have concerns about the impact of 
side effects on school life.
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Children with chronic illness 17 15*
Parents/carers of children with 
chronic illness
27 23*
Parents/carers of children 
receiving intermittent treatment
21 10
Head teachers 55 40
School nurses 20 11
Consultant paediatricians 53 23
Community paediatricians 16 6
Paediatric nurse specialists 42 15
Paediatric pharmacists† 10† 15†
*All completed questionnaire and returned it to the research team 
before leaving the hospital.
†Invitation also posted on Neonatal and Paediatric Pharmacists 
Group message board and an additional five respondents were 
recruited via this route (total of 15 pharmacists recruited).
transcription errors, expired medicines and incorrect 
storage.7–10 One US study found that one in four school 
secretaries with responsibility for administering medi-
cines had not received any training.11 Another study 
reported poor standards of medication management.12 A 
study of parents’ understanding of medication manage-
ment in US schools found poor awareness.13
This study aimed (1) to describe differences between 
how individual schools interpret guidance on how to 
manage medicines (2) to determine the nature of prob-
lems perceived by children, parents, teachers and HCPs 
in relation to medicines management in schools (3) to 
highlight differences between these perceptions.
MethODs
This was a cross-sectional survey study of children (n=15), 
parents (n=33), head teachers (n=40), school nurses 
(n=11) and other HCPs (n=59) (table 1).
Purposive sampling was used. The characteristics of 
participants were specified a priori and recruitment was 
targeted to meet those specifications.
The research team attended local head teacher forums 
to introduce the study. A link to an electronic question-
naire was sent to head teachers of primary, secondary 
and special schools, November 2015—March 2016. A link 
to an electronic questionnaire was sent to HCPs in the 
Local Community Health Trust, in a regional paediatric 
hospital and in two district generals in the UK, August 
2015—April 2016. A reminder email was sent to partic-
ipants at 4 and 6 weeks. A link to the electronic ques-
tionnaire was posted on the Neonatal and Paediatric 
Pharmacists Group (http://www. nppg. org. uk/) message 
board, December 2015.
Children, parents and carers were recruited from 
outpatient clinics, AED and outpatient pharmacy at a 
regional paediatric hospital, January—July 2016. Parents/
carers and children recruited in outpatients completed 
the questionnaire and returned it to the research team 
before they left the hospital. In AED and pharmacy, 
parents/carers supplied informed consent to complete 
a questionnaire over the telephone approximately 1 week 
after their visit.
Questionnaires were designed specifically for this study 
and, adapted for each group (see online supplementary 
file 1 for an example). Questionnaires were either paper-
based or electronic (Snap Survey Software). Responses 
were anonymous.
Since this was an exploratory study, a formal sample size 
calculation was not undertaken. A sample of convenience 
was used, based on the accessibility of participants.
Quantitative data were analysed using summary statis-
tics. Free text was analysed thematically taking both 
an inductive and deductive approach. Free text was 
extracted from the main database and analysed in rela-
tion to each question with the aim of corroborating or 
expanding the closed questions. Text was then analysed 
thematically within subsections of the questionnaire to 
generate broader themes and identify any new concepts 
that emerged and had not been included in the closed 
questions. The research team initially read and discussed 
the free text from a sample of questionnaires and 
developed a coding framework for both the questions 
specific and the broader subsection analysis. A qualita-
tive researcher then used the frameworks to code the rest 
of the free text and the team periodically reviewed the 
process. Responses which exemplified the key themes 
were selected as illustrative examples for inclusion in the 
results section of this report.
Ethical approval for this study was obtained from a 
local NHS Research Ethics Committee (REC), NHS REC 
reference 15/NW/0597, 17.07.15.
results
responses from children and their parents
The median age of children with chronic illness was 13 
years (IQR 10.5–15 years) and the median number of 
medicines required at school was 1.5 (1–2). The median 
age of children about whom parents answered question-
naires was 9.5 years (IQR 6–13 years) and the median 
number of medicines required at school was 2 (1–7.5). 
Of the 15 children who completed a questionnaire, 13 
also had a questionnaire completed by their parent. 
Ten parents of children prescribed intermittent medi-
cines were recruited, their mean age was 7.5 years (IQR 
6.5–8.0), 50% were male.
Nine out of 15 children with chronic illness were happy 
or very happy with how their medicines were dealt with 
at school. Eleven out of 23 parents of children with 
chronic illness were satisfied or very satisfied. However, 
other parents reported specific problems (table 2). Some 
parents reported missed doses (table 2) and described 
how their child’s dependence on school staff to manage 
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Child couldn’t get a dose when they 
needed it
3 5 2 2 24
Child missed a dose 5 5 19 2 17
Child given wrong dose 0 1 6
Child given wrong medicine 1 2
Medicine was lost 0 0 3
Medicine supply ran out 5 4 25 3 9
Medicine was not stored correctly 3 1 10
Side effects stopped child joining in 0 0 5
School not made aware of changes and 
carried on with old medicine/dose
6
Other 1 2 1 10
*The survey for parents/carers of children receiving intermittent treatment did not include these questions.
Box 1 comments from respondents
Parents
‘No doses should be missed’ (MSP6)
‘My daughter feels the school makes too much fuss and she gets 
singled out having to go to an office while her friends eat lunch’ 
(MSP23)
‘My daughter was allowed to self-administer as required it would 
be easier for her’ (MSP25)
‘My child takes care of her own medicines’ (MSP18)
‘The medicine is available but he tends to forget’ (MSP19)
‘I am kept informed about when more medicine is needed. I know 
where the medicine is kept’ (MSP21)
‘His school always follow my instructions regarding his medication 
including, storage, when to give it to him and the best way to 
administer it’ (MSP8)
healthcare professionals
‘Child has to go to the office for his tablet without prompts from 
teacher and due to the nature of disorder frequently forgets’ (CP4)
‘Access to inhalers should be relaxed to improve access […] not 
just ‘call mum’’ (CONS2)
‘Many patients are not allowed to have pain relief on a prn basis’ 
(CONS13)
‘Try to avoid prescribing drugs that need to be given actually at 
school’ (CONS18)
‘Amend medicines schedules to avoid school time administration 
even if that is not ideal’ (P12)
headteachers
‘We work closely with parents’ (HTP23)
‘Myself and our school nurse….liaise with parents on a daily 
basis’ (HTP20) Figure 1 Healthcare professional respondents areas of 
expertise.
their medicines was sometimes restrictive. Other parents 
reported that their child self-medicated at school (box 1) 
or that they had to go into school themselves and admin-
ister each dose.
The majority of children 12/15 and parents 21/24 
were aware of whom to contact at school about their 
medicines. Parents welcomed good communication 
about medicines between themselves and the school and 
one described how the school follows their instructions 
well (box 1).
responses from hcPs
School nurses were responsible for primary schools with 
or without nurseries (n=2) and for schools exclusively for 
children with special needs (n=7), two respondents did 
not specify. Eleven school nurses had children in their 
school(s) taking regular medicines, 10 had children 
needing emergency medicines and nine had children 
taking intermittent treatment. Other HCP respondents 
were from a diversity of clinical specialties (figure 1).
Twenty-eight out of 70 HCPs were satisfied or very satis-
fied with how their patients’ medicines were managed 
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Where are medicines stored?
  Child’s classroom 0 6
  First aid/nurse’s room 8 7
  School/teacher’s/pastoral 
office
12 2
  Children carry them 4 3
Who administers medicines?
  Child’s teacher or 
teaching assistant
10 7
  Named teacher or 
teaching assistant who 
is not the child’s class 
teacher
23 3
  School nurse 2 4
  Children take their own 7 8
  Parents 6 1
  Administrative staff 12 3
  Medication coordinator 2 0
  Pastoral care manager/
mentors
2 0
  Head teacher/senior 
leadership team
2 2
at school. Factors they thought improved medicines 
management included legislation, increased aware-
ness, and the use of medicines that improved a child’s 
symptoms in a way that was of benefit in the classroom 
(eg, medicines for attention deficit and hyperactivity 
disorder). HCPs reported variation in practice and expe-
rience between schools. Others reported poor coopera-
tion from some schools. HCPs reported problems with a 
lack of support for children to engage with taking their 
medicine and with practical issues of access to medicines. 
Others reported children not having access to medicines 
on an ‘as required’ basis. Some HCPs reported adjusting 
prescriptions to accommodate or prevent difficulties at 
school (box 1). Some HCP respondents felt schools relied 
too heavily on policies and protocols resulting in a service 
that was inflexible. However, others felt that there were 
insufficient policies in place to ensure safe and effective 
medicine administration and others recognised the varia-
tion in practice as problematic. School nurses were asked 
about with whom they liaise to resolve problems with chil-
dren’s medicines at school. The most frequently selected 
answers were: parent, community paediatrician and 
hospital consultant. HCPs were asked with whom they 
liaise most often about children’s medicines at school; 
parent, a named teacher and school nurse were the most 
frequently selected answers.
responses from headteachers
Four out of 40 schools accepted verbal instructions 
from parents about medicines, 40 kept a written record 
of what needed to be administered and 39 kept a 
written record of what had been administered. Indi-
viduals designated to receive information about pupils’ 
medicines included class teachers, teaching assistants, 
pastoral care managers and administrative staff. Head 
teachers most frequently received information about 
individual children’s medicines from parents, school 
nurses and hospital nurses. People in a variety of roles 
in schools were responsible for administering medicines 
and storage arrangements for medicines varied between 
schools (table 3).
Thirty-five out of 40 of head teachers were aware of the 
DfE document ‘Supporting pupils at school with medical 
conditions’ but 13 reported some difficulties complying 
with the statutory guidance contained within it. Forty 
out of 40 schools reported that their staff had received 
training on specific medical conditions and on how to 
respond to emergency situations. Training on medicines 
management had been undertaken in fewer schools; 30 
had training on safe storage, 32 had training on admin-
istration and 31 had training on record-keeping. About 
half of head teachers (19/40) reported that they had no 
concerns over the management of medicines in school 
and cited the presence of, and adherence to, policies 
and procedures as a means of measuring the safety and 
quality of medicines management. Twenty-one out of 40 
head teachers thought there was some room for improve-
ment in the overall management of medicines at their 
school and also cited policies and procedures as a means 
of making improvements.
One respondent had experienced problems commu-
nicating with healthcare practitioners while others were 
positive about communication with parents (box 1).
DIscussIOn
This study identified some specific problems which 
relate to medicines management in schools: there are 
inconsistencies in how information about medicines is 
communicated between the healthcare team, families 
and schools, and it is not always timely or effective; doses 
of medicine which are due during the school day are 
not always administered when they should be. Concerns 
about medicines management at school differed 
between stakeholder groups. Parents emphasised the 
need for staff at school to understand their child’s 
condition and their medicines and expressed concerns 
about late or missed doses. Schools acknowledged their 
lack of expertise about medicines and their reliance 
on adherence to policy and procedure and compli-
ance with training but they were reasonably confident 
about their medicines management processes. HCPs 
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expressed concern about missed doses and frustration 
about inconsistency between medicines management 
policies in schools.
This study also identified that the management of 
medicines varies between schools. This is perhaps unsur-
prising when we consider that the guidance on medicines 
management at school provided by the DfE is open to 
interpretation. This study has highlighted how variation 
in how the guidance is implemented has both negative 
and positive impacts for children and their families.
While the overall response rate for this study was high, 
it was lower for some stakeholder groups than for others. 
We postulate that stakeholders who had something to 
say (positive or negative) may have been more likely 
to complete the survey. This study only included stake-
holders in one region; the findings may not reflect prac-
tice in other areas of the UK, although the patient and 
family stakeholder group is drawn from a large geograph-
ical area (circa 5 million).
In a previous UK survey study, fewer than 50% of 
schools in the area surveyed (London) had read the 
contemporaneous DfE document, ‘Supporting pupils 
with medical needs: a good practice guide’.2 In contrast, 
we found that the majority of head teachers were familiar 
with the current update to this DfE document. 98% of 
schools in our study kept a written record of medicines 
administered compared with only 76% in the findings 
published by Wong et al.2 In the same study, support staff 
(eg, school administrators) had the main responsibility 
for managing medicines in most schools; our findings are 
in agreement with this. Although our study was carried 
out in a different part of the UK, our findings indicate that 
the management of medicines in schools in the UK has 
improved over the last decade. One reason why this may 
have changed over the last decade is that cuts in funding 
for school nurses14 have meant that schools have taken on 
more responsibility for the management of children with 
medical conditions. Chakraborty and Hamer3 undertook 
a survey of school medication administration policies in 
Sheffield, UK and determined, in accordance with our 
findings, that the majority of schools had a policy but that 
the content of those policies varied. Some reluctance to 
take on responsibility for the administration of medi-
cines was highlighted in their study and this resonates 
with our findings. An interview study of young people 
with chronic illness identified one similar theme to our 
survey; young people reported barriers to access to medi-
cines at school.4 However, the same study also reported 
that the adverse effects of medicines had a significant 
impact on adherence and school performance, an issue 
not identified in our study. This difference may reflect 
the characteristics of the patient cohort in terms of the 
types of medicines they were taking, although this differ-
ence may also reflect study design. Our patient question-
naire permitted patients to select the response ‘I had 
side effects at school which stopped me joining in with 
activities’; however, none of the respondents selected it. 
An in-depth interview can draw out more information 
from participants, it is known that patients use a variety 
of terms to describe side effects.15
Observation of medicines management practice in 
schools would complement these findings by character-
ising exactly what happens day-to-day in schools. Schools 
would benefit from additional support from other 
schools, children, their families and HCPs to implement 
DfE guidance. Further work should bring together stake-
holders to share their perspectives, to identify what needs 
to be done better and what the mechanism(s) for this 
should be.
cOnclusIOn
Medicines management at school derived from varied 
interpretation of policy and guidance does not always 
meet the needs of children and their families. Specifi-
cally, families reported that communication about medi-
cines is suboptimal and doses of medicine are sometimes 
missed.
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